NCT07608146

Brief Summary

The purpose of this study is to integrate millimeter-wave radar technology to investigate the dynamic movement characteristics of the pelvic floor muscles in patients with different Body Mass Index (BMI) and stress urinary incontinence. Based on this, a large database of pelvic floor movement parameters for Chinese women will be constructed, and a multi-subgroup standard atlas of pelvic floor muscle movement will be established to promote the standardized application of this technology in obstetrics and gynecology clinical assessments. This study also aims to explore the clinical value of pelvic floor movement assessment within the pelvic floor evaluation system, providing directions and insights for establishing a systematic evaluation system and standardizing the diagnosis and treatment of pelvic floor disorders.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
13mo left

Started May 2026

Geographic Reach
1 country

20 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
May 2026Aug 2027

First Submitted

Initial submission to the registry

May 8, 2026

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 27, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

May 30, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

May 27, 2026

Status Verified

May 1, 2026

Enrollment Period

5 months

First QC Date

May 8, 2026

Last Update Submit

May 24, 2026

Conditions

Keywords

Stress urinary incontinencePelvic floor muscle strengthNon-invasive technologyPelvic floor dysfunction

Outcome Measures

Primary Outcomes (1)

  • Pelvic floor movement level assessment

    The outcome measure is the pelvic floor movement level assessed on the magnetic stimulator. The patient is asked to perform pelvic floor muscle contraction and relaxation according to voice prompts, and the assessment data is recorded. The outcome includes maximum/mean values, rise time, and recovery time. The reference maximum or mean value is ≥2.0 and ≥1.5 millimeters. The reference rise and recovery time is \<0.5 second and \<0.7 second.

    2 minutes

Study Arms (2)

Healthy group

Females aged between 18 to 60 without any pelvic floor dysfunction symptoms

Stress urinary incontinence group

Females aged between 18 to 60 years with only stress urinary incontinence symptoms

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Based on BMI values, it is planned to recruit 200 participants with BMI \< 18.5 kg/m², 600 participants with BMI between 18.5 and 24 kg/m², and 200 participants with BMI \> 24 kg/m². A total of 1,000 study subjects will be recruited for healhty group and 1,000 for SUI group, amounting to 2,000 participants in total.

You may qualify if:

  • Female, aged between 18 and 60 years old
  • Signed the informed consent form
  • Healthy group demonstrated no pelvic floor dysfunction
  • SUI group had stress urinary incontinence symptom

You may not qualify if:

  • Participants with cognitive behavioral disorders, mental illnesses, or those who are unable to cooperate
  • Participants who cannot demonstrate correct pelvic floor muscle contraction
  • Participants who were within 1 year postpartum
  • Participants who were post hysterectomy
  • Participants who had pain during internal exam or refused to have internal exam
  • SUI group who had pelvic organ prolapse symptoms or whose POP-Q lowest level reached or exceeded the hymenal ring
  • SUI group had urgency urinary incontinence symptoms
  • SUI group had chronic constipation symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

Anhui Provincial Hospital

Hefei, Anhui, 23001, China

Location

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

Location

Maternal and Child Health Hospital of Linxia Hui Autonomous Prefecture

Linxia, Gansu, 731100, China

Location

The First People's Hospital of Qinzhou

Qinzhou, Guangxi, 535000, China

Location

Guizhou Provincial People's Hospital

Guiyang, Guizhou, 550002, China

Location

Zunyi Maternal and Child Health Hospital

Zunyi, Guizhou, 563000, China

Location

Tangshan Maternal and Child Health Care Hospital

Tangshan, Hebei, 063000, China

Location

Mudanjiang Maternal and Child Health Hospital

Mudanjiang, Heilongjiang, 157000, China

Location

People's Hospital of Zhengzhou

Zhengzhou, Henan, 450000, China

Location

The Second Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, 450000, China

Location

the First Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210029, China

Location

Zaozhuang Municipal Hospital

Zaozhuang, Shandong, 277102, China

Location

Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, 200072, China

Location

Shanghai Sixth People's Hospital

Shanghai, Shanghai Municipality, 200233, China

Location

Shanxi Maternal and Child Health Hospital

Taiyuan, Shanxi, 030013, China

Location

Chengdu Fifth People's Hospital

Chengdu, Sichuan, 611130, China

Location

The Second Hospital of Tianjin Medical University

Tianjin, Tianjin Municipality, 300211, China

Location

The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, 830054, China

Location

Yan'an Hospital Affiliated to Kunming Medical University

Kunming, Yunnan, 650032, China

Location

Ningbo Ninth Hospital

Ningbo, Zhejiang, 315020, China

Location

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Lan Zhu, Doctor

    Peking Union Medical College Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department Chair

Study Record Dates

First Submitted

May 8, 2026

First Posted

May 27, 2026

Study Start

May 30, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

August 31, 2027

Last Updated

May 27, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations